Abstract : Ginsenosides are among the most well-known traditional herbal medicines frequently used for the treatment of cardiovascular symptoms in South Korea. The anti-ischemic effects of compound K (CK), a metabolite of ginsenoside Rb1, on ischemia-induced isolated rat hearts were investigated through the analyses of the changes in the hemodynamics (blood pressure, aortic flow, coronary flow, and cardiac output) and the measurement of the infarct region. The subjects in this study were divided into four groups: the normal control, the CK-alone group, the ischemia-induced group without any treatment, and the ischemia-induced group treated with CK. No significant differences in perfusion pressure, aortic flow, coronary flow, and cardiac output were found between the groups before ischemia was induced. The oxygen and buffer supply was stopped for 30 min to induce ischemia 60 min after reperfusion in the isolated rat hearts, and the CK was administered 5 min before ischemia induction. The CK treatment significantly prevented decreases in perfusion pressure, aortic flow, coronary flow, and cardiac output under ischemic conditions. In addition, the hemodynamics (except for the heart rate) of the group treated with CK significantly recovered 60 min after reperfusion, unlike in the control group. CK significantly limited the infarct. These results suggest that CK treatment has distinct anti-ischemic effects in an exvivo model of an ischemia-reperfusion-induced rat heart.
INTRODUCTION
Panax ginseng has been popularly used as a herbal medicine in Asia for more than 2000 years and currently occupies an important place among the tonic remedies of oriental medicine. Ginseng's genus name Panax is derived from the Greek words pan (all) and akos (cure), meaning cure-all. Ginseng root has been used extensively in Korean and Chinese medicine and has become increasingly popular in the western world for its alleged tonic effect and possible curative and restorative properties. There are increased clinical evidences concerning the potential benefits of ginseng roots in cardiovascular diseases. Administration of ginsenosides, a mixture of saponins extracted from Panax ginseng, decreases blood pressure in both hypertensive patients and experimental animals. 1, 2) Ginsenosides, which is considered to be a biologically active fraction of P. ginseng, is a mixture of triterpene glycosides. The major components of ginsenosides belong either to the protopanaxadiol or protopanaxatriol groups.
3) It has also been shown that ginsenosides enhance vasodilatory response to perivascular nerve stimulation in monkey cerebral arteries. 4) The antihypertensive effects of ginsenosides may result from their ability to inhibit vascular tone. In previous study, it was showed that ginsenoside Rg 3 inhibited Ca 2+ -induced vascular contraction, 5, 6) and that the intracellular accumulation of Ca 2+ is a crucial factor for the irreversible myocardial injury that occurs after reperfusion following a prolonged period of ischemia. 7, 8) According to Bourdillon and Poole-Wilson, 9 ) the accumulation of Ca 2+ was not due to a decrease in efflux, but due to an increase in influx. The mechanisms of ischemia/reperfusion (I/R) injury include the production of reactive oxygen species (ROS), abnormal lipid metabolism, and calcium overload. 10) It has been well known that Ca 2+ overload due to Na + -Ca 2+ exchange and L-type calcium channel opening leads to increase [Ca 2+ ]i. 11) And, it was reported that excessive accumulation of cytosolic Ca 2+ is taken up by mitochondria during I/R, resulting in an increase in mitochondrial Ca 2+ level, which may stimulate the opening of the mitochondrial permeability transition and the release of proapoptotic factors. 12, 13) However, it is not reported for any antiischemic effect of compound K (CK), a metabolite of ginsenoside Rb1, ex vivo. In addition, because of the adverse effects associated with anti-ischemia drugs, many trials have been recently performed to find and develop new anti-ischemic drugs through herbal medicines that would minimize side effects. Numerous studies of various herbal medicines have been performed, and some have reported significant improvements in controlling ischemic symptoms without any noticeable adverse effects. 14) Given those backgrounds, we previously showed that ginsenoside metabolite CK inhibited Ca 2+ channel subtype, 15) providing new insights into one possible mechanism underlying the beneficial effects of ginsenosides in the cardiovascular and nervous systems. However, since activity in vitro does not necessarily reflect in organ level activity, the current study was conducted to determine whether the apparent activity of CK on cardioprotection was reflected ex vivo using perfused heart model. After all, after we determined the maximum effective dose of CK during I/R injury, we intensively examined the cardioprotective effects of the CK using an ex vivo Langendorff system.
METERIAL AND METHODS

Drugs
As shown in Fig. 2 , CK was kindly obtained from Korea Ginseng Corporation (Daejon, Korea). Compound K was dissolved in DMSO as a concentrated stock and further diluted to its final concentration in saline. When ischemia was started, the stock solutions of CK was diluted with perfusate before use. We found the final concentration of DMSO (<0.01%) had no effect on the neuronal cell (data not shown). All other chemical agents were purchased from Sigma (St. Louis, MO, USA) unless otherwise specified.
Animals
Male Sprague-Dawley rats weighing 250 to 300 g were supplied by Charles River (KFT). The rats were fed a standard rodent pellet chow and housed with free access to commercial food pellets (LSM, Bacutil, Poland), as well as tap water ad libitum under strictly controlled pathogen-free conditions (room temperature: 23±1 o C, relative humidity: 50±10%, light cycle: 07:00-19:00). And, the rats were acclimatized to their environment for 2 
Experimental protocol
The subjects in this study were divided into four groups (n=12, each group): normal control group, 100 µM CK control group, an ischemia control group, and 100 µM CK administrated group before ischemia. Forty eight animals were randomly divided into four groups, A1: normal control group with modified modified KrebsHenseleit (KH) solution, A2: 100 µM CK control group with no ischemia, A3: ischemia control group with no administration of CK and A4: 100 µM CK administrated group with I/R induction (administration of 100 µM CK before ischemia followed by reperfusion with modified KH buffer for 60 min). Namely, 100 µM CK was added 5 min before ischemia were induced in isolated hearts. All hearts were perfused for 20 min before the following perfusion protocol for equilibration (Fig. 1) .
Heart preparation and perfusion apparatus Sprague Dawley rats were anesthetized with intraperitoneal pentobarbital sodium (50 mg/kg). Heparin (1000 U/ kg) was injected through a femoral vein to prevent blood coagulation. The hearts were rapidly excised and placed in ice-cold (4 o C) Krebs-Henseleit (KH) bicarbonate buffer (NaCl 120.0 mM, NaHCO 3 25 mM, KCl 4.8 mM, KH 2 PO 4 1.2 mM, CaCl 2 1.25 mM, MgSO 4 1.2 mM, and glucose 11.0 mM). Aorta and left atrium cannulation was performed rapidly, and the hearts were perfused in Langendorff mode at a pressure of 100 cm H 2 O with KH buffer. The buffer was saturated with 95% O 2 / 5% CO 2 at pH 7.4 and thermostatically kept at a constant temperature of 37 o C. Global ischemia was achieved by clamping both the aortic and atrial lines for 10 min. In Langendorff perfusion (non-working heart model), perfusion fluid entered the heart via the aorta retrograde from the aortic reservoir located 100 cm above the heart. The aortic reservoir, which was the thermostatically maintained oxygenator, carried out a perfusate to the aorta at a 100 cm H 2 O hydrostatic pressure maintained with the use of a constant head device (CHD). This system maintains the function of the heart, but does not maintain circulation of perfusate to the ventricle. Such a system is used to recover and maintain heart function for 15 min after isolation and ischemia induction. In the working heart model, the left atrium cannula and aortic cannula were open and perfusion fluid entered the heart via the left atrium from an atrial bubble trap located 20 cm above the heart. The left ventricle ejected perfusate via the aorta and elasticity chamber (aortic pressure chamber) against a 20 cm H 2 O hydrostatic pressure to the aortic bubble trap. The same system is used to maintain heart function 20 min before induction of heart ischemia, and to recover heart function for 60 min after ischemia using the Langendorff system. The system makes it possible to compare the recovery of heart function before and after induction of heart ischemia. Aortic and coronary perfusates were not recirculated in the present study. The entire apparatus was thermostatically maintained by a water jacket and coil heat chamber. Aortic flow and coronary flow were measured by timed collection of perfusate from the aortic and pulmonary trunk cannula, respectively. Cardiac output was calculated by summing the aortic and coronary flows. Heart rate was obtained by an ECG monitoring system (S & W Medico Teknik A/S, Denmark) with three electrodes attached to the epicardium. Systolic and diastolic aortic pressures were measured throughout the working heart model perfusion periods in the aortic outflow line with a hemodynamics monitoring system (S & W Medico Teknik A/S, Denmark).
Ischemia induction of isolated-perfused rat heart
Male Sprague-Dawley rats were anesthetized with intraperitoneal pentobarbital sodium (50 mg/kg). The hearts were rapidly excised and mounted on a Langendorff apparatus (IPH-W, Labo Support, Osaka, Japan) via the aorta, and then perfused at a constant pressure of 65 mmHg with KH buffer. The heart was constantly warmed by a circulating water jacket at 37 o C. The buffer was gassed with 95% O 2 / 5% CO 2 at pH 7.4. To measure left ventricular pressure, a pressure transducer was connected to the aortic cannula. Heart rate was monitored from left ventricular pressure. Coronary flow was measured by coronary flow volume (ml/min). After stabilization (non-working system) to 100 cm H 2 O for 15 min via the aortic cannula, the perfusion pressure was reduced to 20 cm H 2 O for 20 min at the LA cannula (working system), and then ischemia was induced for 5 min accompanied by the injection of hearts. Then, the hearts were divided into the normal control group (A1), the CK control group (A2), the ischemia control group (A3) and the CK administrated group (A4), which received administration of CK before ischemia induction.
CK for 2 min (flow rate 10ml/min). Then, the perfusate was injected into the aortic line for 2 min to observe the effects of CK on an ischemia-induced heart. Ischemic conditions were maintained for 3 additional min. The isolated hearts underwent a total 5 min period of normothermic (37 o C) no-flow ischemia. In the control group, equal volumes of KH buffer were injected into the aortic line for 2 min. Those hearts were retrograde perfused for 15 min according to the Langendorff method as described by Li et al. 16) to recover heart function. Then, the heart was perfused again through the working heart system for 60 min in the period of post-ischemia. The functional recovery rates between the ischemia group and ischemia group with the treatment of the CK after ischemia induction were compared through changes in perfusion pressure, aortic flow, coronary flow, and cardiac output to observe the anti-ischemia effect of the CK.
Measurement of infarct region
Measurement was performed according to the method as described previously. 17) In brief, to determine the extent of myocardial infarction after 60 min of reperfusion, the left ventricular slices were incubated at 37 o C in 1% triphenyltetrazolium chloride (TTC) phosphate buffered saline for 15 min. The outlines of the slices and TTC negative (infarct area) of white colour area were traced and photographed in colour. The sizes of infarct region were estimated by planimetry with Leica QWin software. Infarct regions were expressed as the percent of total area (100%).
Statistical analysis
The results are presented as the mean±SEM. Statistical significance was compared between the treatment and control groups by Student's t-test. Results with a p<0.05 were considered statistically significant.
RESULTS AND DISSCUSSION
Determination of maximal effective dose of the CK
The maximum effective amount of CK on ischemiainduced isolated rat heart was assessed by measuring cardiac output, the direct parameter of heart function, with and without CK after I/R while increasing the doses of CK from 1, 3, 10 and 30 µM. As shown in Fig. 2 , there was no difference between groups without and with 100 µM CK under no ischemic conditions (N/C vs. CK alone = 95.45±2.5 vs. 95.8±3.4). This result suggests that CK itself does not influence cardiac output in normal conditions. In the present studies. the maximum recovery effect for cardiac output after I/R was obtained with the 100 and 300 µM CK (58.7±3.7 vs. 60.7±3.5, respectively). There was no significantly difference between doses of 100 and 300 µM on cardiac output after I/R. However, 100 and 300 µM of CK, the concentrations of maximum recovery effect for cardiac output, are very high concentrations for application. Also, the recovery of cardiac output between treatment of 1, 3, 10 and 30 µM of CK was not significantly different (42.5±3.1 ml/min with 1 µM, 42.6±2.9 with 3 µM, 43.5±3.8 with 10 µM and 51.5±3.2 ml/min with 30 µM, respectively). Thus, 100 µM was determined to be the appropriate dose of CK, respectively to optimize the anti-ischemic effect on ischemia-induced isolated rat heart (Fig. 3) .
Heart rate in I/R-induced isolated rat heart
Since it is well-known that heart rate does not significantly change under ischemic conditions, 18, 19) the heart rate of I/R-induced isolated rat heart was assessed. As shown in Table 1 , the average heart rate during the preischemic and post-ischemic periods was not significantly different. Also, the heart rate between the control and the CK groups under post-ischemic conditions was not significantly different. These results indicate that heart rate does not change in I/R-induced isolated rat heart regardless of the treatment of CK.
Recovery effect of the CK on perfusion pressure Perfusion pressure was substantially decreased by I/R conditions under post-ischemic periods. However, such decreases were partially recovered by treatments of CK compared with normal control. These anti-ischemic effects of CK on perfusion pressure were continuously observed for 10 to 60 min during the post-ischemic period in each group. Thus, treatment of CK significantly recovered the perfusion pressure reduced by I/R for 60 min postischemia (**p<0.01, Table 2 and Fig. 4 ). In addition, any effects of CK on perfusion pressure were not significantly observed in corresponding times with ischemia group, namely 5 to 20 min during the pre-ischemic period and 10 to 60 min during the post-ischemic period (normal control Fig. 3 . Determination of maximum dose of that results in maximum anti-ischemic effect. Cardiac output was measured throughout the working heart model perfusion periods in the aortic flow plus coronary flow with a hemodynamic monitoring system in both groups to detect the maximal anti-ischemia effect according to dose of CK (1-300 µM). Black histograms represent the mean±SEM from twelve rats per control group without any treatment under no ischemia conditions (A1 ischemia-induced isolated rat heart. Perfusion pressure was measured throughout the working heart model perfusion periods in the aortic outflow line with a hemodynamic monitoring system in the control and treatment groups of CK to detect an anti-ischemia effect. Each symbol represents the mean±SEM from twelve rats per group with ( ) denoting the normal control group without any treatment and ischemia (A1), ( ) the treatment group of CK under normal conditions without ischemia (A2), ( ) the treatment group of CK under ischemic conditions (A3), and ( ) the I/R group without any treatment. **p<0.01 vs. control group under ischemic conditions based on Student's t-test.
vs. CK, p>0.05, Tabel 2, Fig. 4 ).
Recovery effect of the CK on aortic flow
Aortic flow was substantially decreased by I/R compared with normal control under post-ischemic conditions. However, such decreases were recovered by treatments of CK. These anti-ischemic effects of CK on aortic flow were continuously observed for 10 to 60 min during the post-ischemic period in each group. Thus, treatment of CK significantly recovered the aortic flow reduced by ischemia for 60 min post-ischemia (**p<0.01, Table 3 and Fig. 5) . Also, any effects of CK on aortic flow were not significantly observed in corresponding times with ischemia group alike perfusion pressure (normal control vs. CK, p>0.05, Tabel 3, Fig. 5 ).
Recovery effect of the CK on coronary flow
Induction of ischemia elicits a substantial decrease in coronary flow compared to control. However, treatment of CK dramatically recovered coronary flow under no ischemic conditions. Such recovery continued from 30 to 60 min in the working heart model after ischemia was induced. As well as aortic flow, any difference between normal control and the CK alone group on coronary flow were not significantly observed in corresponding times with ischemia group for 5 to 20 min during the pre-ischemic period and 10 to 60 min during the post-ischemic period (normal control vs. CK, p>0.05, Tabel 4, Fig. 6 ).
Recovery effect of the CK on cardiac output
Cardiac output was substantially decreased by induction of ischemia compared with normal control. However, such decreases were significantly recovered by the treatment of CK under no ischemic conditions. Thus, in the working heart model during the post-ischemic period, Fig. 5 . Recovery effect of the CK on aortic flow of ischemiainduced isolated rat heart. Aortic flow was measured by timed collection of perfusate from the aortic cannula in each group to detect an anti-ischemia effect. Each symbol represents the mean±SEM from twelve rats per group with ( ) denoting the normal control group without any treatment and ischemia (A1), ( ) the treatment group of CK under normal conditions without ischemia (A2), ( ) the treatment group of CK under ischemic conditions (A3), and ( ) the I/R group without any treatment. **p<0.01 vs. control group under ischemic conditions based on Student's t-test. CK significantly recovered decreases in cardiac output (**p<0.01, Table 5 and Fig. 7) . Also, any effects of CK on cardiac output were not observed in corresponding times with ischemia group for 5 to 20 min during the preischemic period and 10 to 60 min during the postischemic period (normal control vs. CK, p>0.05, Tabel 5, Fig. 7 ).
Size of infarct
There was no significant difference in area at risk among normal control (A1), CK alone groups (A2). There were significant differences in infarct regions among I/R group (A3) and CK treated group (A4). Compared to normal control as 100%, CK treated group (15.7%±3.5%) decreased significantly in both infarct region compared with I/R group (38.3±5.6% ) (Fig. 8) .
The results from this study show that the CK significantly recovered the hemodynamics functions after I/R injury (decreased perfusion pressure, aortic flow, coronary flow and cardiac output), but without influencing heart rate. One of the main indicators of ischemia-induced cardiac cell death is derived from the disturbance of intracellular Ca 2+ homeostasis. Recent reports showed that under ischemic conditions, myocardial oxidative metabo- 22) . Also, reactive oxygen species and metabolites are known to play important roles in the pathogenesis of I/R and anoxia/reoxygenation injury. 21) The reduction of O 2 results in the production of superoxides as well as hydrogen peroxide (H 2 O 2 ). H 2 O 2 is highly diffusible and induces cell damage. H 2 O 2 appears to affect not only lipids but also transmembrane proteins. The hydroxyl radical (OH) also participates in lipid hyperoxidation.
21) It was reported that in ischemia-reperfused heart, generation of reactive oxygen species and Ca 2+ overload may correlate cardiac dysfunction. [21] [22] [23] Besides, in ischemia-reperfused cardiomyocytes, intracellular Ca 2+ overload and reactive oxygen species production are suggested to be involved in the progression of apoptosis or necrosis, and may mediate signals to the nucleus, leading to altered gene transcription. 24) And, in the pathophysiology of ischemic contractile dysfunction, reactive oxygen species and intracellular Ca 2+ overload modulate cardiomyocyte contractility through phosphorylation of various kinases, especially PKC and p38 kinase. 25, 26) In addition, reactive oxygen species have been shown to interfere with Ca 2+ transport systems across the sarcolemmal membrane. 27, 28) Therefore, in present studies, the protective effects of CK might be due to modulation of any number of different physiological processes that are involved in the development of I/R injury. So, what is the mechanism underlying the protective effect of CK against ischemia-caused cardiac dysfunction ex vivo? One possibility is that these CK-induced protection against myocardial ischemia might be derived from the inhibition on ischemia-induced Ca 2+ influx via L-and other types of Ca 2+ channel since panaxadiol saponins and panaxatriol saponins block Ca 2+ channel in the cultured cardiac cells 29) and ginsenoside block Ca 2+ channel and anti-freeradical actions.
30) Also, we have shown that ginsenoside inhibit L-, N-, and P/Q-types of Ca 2+ channels [31] [32] [33] [34] and CK inhibit voltage-dependent Ca 2+ channel subtypes.
18)
The second possibility is that myocardial protection of CK against cardiac I/R might be derived from the attenuation of oxidative stress caused by hypoxia, since ginsenosides inhibit overproduction of NO and malonyldiadehyde and prevented a decrease of superoxide dismutase activ- ity. 30, 35, 36) Given that ginsenosides possesses vasodilative properties, 37, 38) this also may be a potential benefit of this agent against the 'no-reflow' in ischemic heart. In this study, the protective effects of CK lasted for at least 60 min in post-ischemic conditions. It is too early to say whether the pre-treatment of CK would continue to provide ongoing protection beyond this time point. Clearly, further studies are required to clarify these issues. Nevertheless, in present study we showed that CK is a compound without toxicity because of no difference in hemodynamic parameters between normal control and CK alone treatment, that provide protective effects in myocardium IR injury. These results demonstrate that CK have distinct anti-ischemic effects. However, the molecular mechanism of CK with respect to its anti-ischemic effects should be studied further before firm conclusions are drawn. In summary, using a rodent Langendorff model system that shows a mydiocardial I/R injury, we obtained results suggesting that CK has cardioprotective effects against myocardial I/R injury.
CONCLUSIONS
The anti-ischemic effects of CK on ischemia-induced isolated rat heart were investigated through analyses of changes in hemodynamic functions (perfusion pressure, aortic flow, coronary flow, and cardiac output). Treatment of CK significantly prevented decreases in hemodynamics under ischemic conditions. And, CK significantly limited the infarct. These results suggest that CK has distinct antiischemic effects. Also, these results support the development of a novel anti-ischemia agent based on the pharmacological actions of CK.
